Last edition
News about
Dr Reddy's inks Rs 1,850-crore deal with Wockhardt; to acquire 62 brands & Baddi unit
Dr Reddy's Laboratories on Wednesday announced it would acquire Wockhardt's select divisions of branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives for consideration for Rs 1,850 crore.
Biocon receives 3 USFDA observations for insulin facility in Malaysia
At the conclusion of the inspection, the agency issued a Form 483 with three observations which we believe are procedural in nature
Abbott launches new four-strain flu vaccine for wide protection against influenza
Globally approved, this 3rd generation quadrivalent vaccine, offers wide coverage protection against four flu virus strains for children and adults vs. three strains in previous generation Sub-unit vaccines offer similar immunization benefits with better tolerability compared to other flu vaccine types, with lesser side effects.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy